Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
Authors:
- 9 April 2020
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 181 (2) , 347-359
Abstract
Purpose Sexual dysfunction is an important concern of premenopausal women with early breast cancer. We investigated predictors of sexual problems in two randomized controlled trials. Methods A subset of patients enrolled in TEXT and SOFT completed global and symptom-specific quality-of-life indicators, CES-Depression and MOS-Sexual Problems measures at baseline, six, 12 and 24 months. Mixed models tested the association of changes in treatment-induced symptoms (baseline to 6 months), depression at 6 months, and age at randomization with changes in sexual problems over 2 years. Results Sexual problems increased by 6 months and persisted at this level. Overall, patients with more severe worsening of vaginal dryness, sleep disturbances and bone or joint pain at 6 months reported a greater increase in sexual problems at all time-points. Depression scores were significantly associated with sexual problems in the short-term. All other symptoms had a smaller impact on sexual problems. Age was not associated with sexual problems at any time-point. Conclusion Among several key symptoms, vaginal dryness, sleep disturbance, and bone and joint pain significantly predicted sexual problems during the first 2 years. Early identification of these symptoms may contribute to timely and tailored interventions.Keywords
Funding Information
- Pfizer
- Ipsen Biopharmaceuticals
This publication has 60 references indexed in Scilit:
- Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendationsBreast Cancer Research and Treatment, 2013
- The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective studyBreast Cancer Research and Treatment, 2013
- Quality of life and sexual functioning in young women with early‐stage breast cancer 1 year after lumpectomyPsycho-Oncology, 2012
- Sexual dysfunction in young women with breast cancerSupportive Care in Cancer, 2012
- Prevalence and associated factors of sexual problems after early‐stage breast cancer treatment: results of a French exploratory surveyPsycho-Oncology, 2011
- Sexual Function After Breast CancerThe Journal of Sexual Medicine, 2011
- Changes in sexual problems over time in women with and without early-stage breast cancerMenopause, 2010
- Initial report of the cancer Patient‐Reported Outcomes Measurement Information System (PROMIS) sexual function committeeCancer, 2009
- Adjuvant Chemotherapy Followed By Goserelin Compared With Either Modality Alone: The Impact on Amenorrhea, Hot Flashes, and Quality of Life in Premenopausal Patients—The International Breast Cancer Study Group Trial VIIIJournal of Clinical Oncology, 2007
- The CES-D ScaleApplied Psychological Measurement, 1977